MC1264A1 - Procede de preparation de benzylpyrimides et de medicaments contenant ces substances - Google Patents

Procede de preparation de benzylpyrimides et de medicaments contenant ces substances

Info

Publication number
MC1264A1
MC1264A1 MC791383A MC1383A MC1264A1 MC 1264 A1 MC1264 A1 MC 1264A1 MC 791383 A MC791383 A MC 791383A MC 1383 A MC1383 A MC 1383A MC 1264 A1 MC1264 A1 MC 1264A1
Authority
MC
Monaco
Prior art keywords
benzylpyrimides
substances
preparation
medicaments containing
medicaments
Prior art date
Application number
MC791383A
Other languages
English (en)
Inventor
J Burchall
S Bushy
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1264A1 publication Critical patent/MC1264A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MC791383A 1978-05-24 1979-05-23 Procede de preparation de benzylpyrimides et de medicaments contenant ces substances MC1264A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2193878 1978-05-24

Publications (1)

Publication Number Publication Date
MC1264A1 true MC1264A1 (fr) 1980-03-28

Family

ID=10171323

Family Applications (1)

Application Number Title Priority Date Filing Date
MC791383A MC1264A1 (fr) 1978-05-24 1979-05-23 Procede de preparation de benzylpyrimides et de medicaments contenant ces substances

Country Status (12)

Country Link
EP (1) EP0006987A1 (fr)
JP (1) JPS54154775A (fr)
AU (1) AU4732579A (fr)
DK (1) DK214479A (fr)
FI (1) FI791638A (fr)
IL (1) IL57375A0 (fr)
IT (1) IT1117752B (fr)
MA (1) MA18450A1 (fr)
MC (1) MC1264A1 (fr)
NO (1) NO791699L (fr)
PT (1) PT69656A (fr)
ZW (1) ZW9979A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0054756B1 (fr) * 1980-11-27 1986-07-23 The Wellcome Foundation Limited Benzylpyrimidines antibactériennes
HU188588B (en) * 1982-08-13 1986-04-28 Egyt Gyogyszervegyeszeti Gyar Process for the production of 2,4-diamino-5-benzyl-pyrimidine-derivatives
FR2652812A1 (fr) * 1989-10-09 1991-04-12 Rhone Poulenc Chimie Procede de preparation de difluoro-2,2 benzodioxole-1,3.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB875562A (en) * 1957-02-21 1961-08-23 Wellcome Found Improvements in and relating to pyrimidine derivatives and the preparation thereof
GB1128234A (en) * 1966-02-19 1968-09-25 Wellcome Found 5-benzylpyrimidine derivatives and process for the preparation thereof
CH544053A (de) * 1966-05-09 1973-11-15 Hoffmann La Roche Verfahren zur Herstellung von Sulfonamidderivaten
US3684810A (en) * 1970-03-11 1972-08-15 Hoffmann La Roche Process for 2,4-diamino-5-(3,5-dimethoxy-4-hydroxybenzyl) pyrimidine
GB1375162A (fr) * 1970-10-22 1974-11-27
GB1413472A (en) * 1971-10-12 1975-11-12 Wellcome Found 2,4-diamino pyrimidines
BE789904A (fr) * 1971-10-12 1973-04-10 Wellcome Found Procedes de synthese organique
DE2546667C3 (de) * 1975-10-17 1978-10-12 Ludwig Heumann & Co Gmbh, 8500 Nuernberg 2,4-DiamüH»-5-(3-methoxy-4-hydroxy-5-halogenbenzyl)-pyrimidine, und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
NO791699L (no) 1979-11-27
IL57375A0 (en) 1979-09-30
MA18450A1 (fr) 1979-12-31
DK214479A (da) 1979-11-25
PT69656A (en) 1979-06-01
FI791638A (fi) 1979-11-25
IT1117752B (it) 1986-02-24
EP0006987A1 (fr) 1980-01-23
JPS54154775A (en) 1979-12-06
AU4732579A (en) 1979-11-29
IT7949150A0 (it) 1979-05-23
ZW9979A1 (en) 1980-12-24

Similar Documents

Publication Publication Date Title
LU79685A1 (fr) Procede de preparation de nouveaux isomeres dextrogyres de spiro-hydantoines asymetriques et de compositions pharmaceutiques les contenant
PT77488B (fr) Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant
MC1241A1 (fr) Derives de l'imidazole et leur preparation et preparation de medicaments contenant ces substances
DE2962631D1 (en) Process for the sterilization of pharmaceutical products
IT1203231B (it) Apparecchio per ispezionare l'aseptto esterno di medicine solide
LU78330A1 (fr) Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant
BE875089A (fr) Procede de preparation de tetrahydrobenzoxocines et de cishexahydrodibenzopyranones
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
MY8700122A (en) N-oxacyclic-alkylpeperidyl-diazacompounds process for their manufacture and pharmaceutical compositions containing them
PT69132A (fr) Procede pour la preparation de systemes porteurs liposomiqes pour medicaments
BE879472A (fr) Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
BE880578A (fr) Procede de preparation de corps moules contenant des dechets hautement radioactifs
BE885156A (fr) Psoralenes, leur procede de preparation et compositions pharmaceutiques les contenant
BE875939A (fr) Procede et preparation de 6-hallo-pregnanes
BE838213A (fr) Nouveaux ethers d'oximes, procede de preparation de ceux-ci et medicaments les contenant
BE865601A (fr) Medicaments contenant des alcenylxanthines et leur procede de preparation
IT7950138A0 (it) Composizione farmaceutica per il trattamento dei parkinsonismi
BE875378A (fr) Procede de preparation d'alcoylsilanes
RO78342A (fr) Procede de preparation des imino-ethers de benzthiazolines et benzoxazolines
MC1264A1 (fr) Procede de preparation de benzylpyrimides et de medicaments contenant ces substances
PT77751B (fr) Procede de preparation de derives benzylideniques soufres et de compositions pharmaceutiques le contenant
BE878836A (fr) Derives d'acide hydroxamique, leur procede de preparation et medicament les contenant
PT70005A (fr) Procede de preparation de nouveaux derives de 6-methoxy-2-acetylnaphtalene oxime et des compositions pharmaceutiquesles contenant
FR2621918B1 (fr) 2',3'-didesoxy-4-thio-uridines, procede de preparation de ces substances et medicaments qui en contiennent
BE884171A (fr) Nouveaux derives de l'ergol-8-ene et de l'ergoline, procede de preparation de ces derives et medicaments les contenant

Legal Events

Date Code Title Description
YP Annual fee paid